45 related articles for article (PubMed ID: 34455393)
21. Disrupting the nNOS/NOS1AP interaction in the medial prefrontal cortex impairs social recognition and spatial working memory in mice.
Candemir E; Fattakhov N; Leary AO; Slattery DA; Courtney MJ; Reif A; Freudenberg F
Eur Neuropsychopharmacol; 2023 Feb; 67():66-79. PubMed ID: 36513018
[TBL] [Abstract][Full Text] [Related]
22. Interaction of NOS1AP with the NOS-I PDZ domain: Implications for schizophrenia-related alterations in dendritic morphology.
Candemir E; Kollert L; Weißflog L; Geis M; Müller A; Post AM; O'Leary A; Harro J; Reif A; Freudenberg F
Eur Neuropsychopharmacol; 2016 Apr; 26(4):741-55. PubMed ID: 26861996
[TBL] [Abstract][Full Text] [Related]
23. Unexpected Heterodivalent Recruitment of NOS1AP to nNOS Reveals Multiple Sites for Pharmacological Intervention in Neuronal Disease Models.
Li LL; Melero-Fernandez de Mera RM; Chen J; Ba W; Kasri NN; Zhang M; Courtney MJ
J Neurosci; 2015 May; 35(19):7349-64. PubMed ID: 25972165
[TBL] [Abstract][Full Text] [Related]
24. ZLc002, a putative small-molecule inhibitor of nNOS interaction with NOS1AP, suppresses inflammatory nociception and chemotherapy-induced neuropathic pain and synergizes with paclitaxel to reduce tumor cell viability.
Lee WH; Carey LM; Li LL; Xu Z; Lai YY; Courtney MJ; Hohmann AG
Mol Pain; 2018; 14():1744806918801224. PubMed ID: 30157705
[TBL] [Abstract][Full Text] [Related]
25. Hippocampal nuclear factor kappa B accounts for stress-induced anxiety behaviors via enhancing neuronal nitric oxide synthase (nNOS)-carboxy-terminal PDZ ligand of nNOS-Dexras1 coupling.
Zhu LJ; Ni HY; Chen R; Chang L; Shi HJ; Qiu D; Zhang Z; Wu DL; Jiang ZC; Xin HL; Zhou QG; Zhu DY
J Neurochem; 2018 Sep; 146(5):598-612. PubMed ID: 29858554
[TBL] [Abstract][Full Text] [Related]
26. Hippocampal overexpression of NOS1AP promotes endophenotypes related to mental disorders.
Freudenberg F; Candemir E; Chen X; Li LL; Esen-Sehir D; Schenk N; Kinoshita M; Grünewald L; Frerichs V; Fattakhov N; Manchen J; Bikas S; Kumar A; OLeary A; Slattery DA; von Engelhardt J; Courtney MJ; Reif A
EBioMedicine; 2021 Sep; 71():103565. PubMed ID: 34455393
[TBL] [Abstract][Full Text] [Related]
27. Research progress in NOS1AP in neurological and psychiatric diseases.
Wang J; Jin L; Zhu Y; Zhou X; Yu R; Gao S
Brain Res Bull; 2016 Jul; 125():99-105. PubMed ID: 27237129
[TBL] [Abstract][Full Text] [Related]
28. Neuronal nitric oxide synthase (NOS1) and its adaptor, NOS1AP, as a genetic risk factors for psychiatric disorders.
Freudenberg F; Alttoa A; Reif A
Genes Brain Behav; 2015 Jan; 14(1):46-63. PubMed ID: 25612209
[TBL] [Abstract][Full Text] [Related]
29. The Physiological Function of nNOS-Associated CAPON Proteins and the Roles of CAPON in Diseases.
Xie W; Xing N; Qu J; Liu D; Pang Q
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958792
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of NOS1AP action on NMDA receptor-nNOS signaling.
Courtney MJ; Li LL; Lai YY
Front Cell Neurosci; 2014; 8():252. PubMed ID: 25221472
[TBL] [Abstract][Full Text] [Related]
31. Glutamatergic postsynaptic density protein dysfunctions in synaptic plasticity and dendritic spines morphology: relevance to schizophrenia and other behavioral disorders pathophysiology, and implications for novel therapeutic approaches.
de Bartolomeis A; Latte G; Tomasetti C; Iasevoli F
Mol Neurobiol; 2014 Feb; 49(1):484-511. PubMed ID: 23999870
[TBL] [Abstract][Full Text] [Related]
32. nNOS and Neurological, Neuropsychiatric Disorders: A 20-Year Story.
Zhu LJ; Li F; Zhu DY
Neurosci Bull; 2023 Sep; 39(9):1439-1453. PubMed ID: 37074530
[TBL] [Abstract][Full Text] [Related]
33. "NO" Time in Fear Response: Possible Implication of Nitric-Oxide-Related Mechanisms in PTSD.
Fronza MG; Ferreira BF; Pavan-Silva I; Guimarães FS; Lisboa SF
Molecules; 2023 Dec; 29(1):. PubMed ID: 38202672
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
